Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Milrinone Generic Health Milrinone 1mg/mL Concentrate for injection Max Health Limited Cenexi SAS, Fontenay-sous-Bois, France
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
NovoEight Turoctocog alfa 250IU Powder for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Gentofte, Denmark
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
NovoEight Turoctocog alfa 500IU Powder for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Gentofte, Denmark
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
NovoEight Turoctocog alfa 1000IU Powder for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Gentofte, Denmark
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
NovoEight Turoctocog alfa 1500IU Powder for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Gentofte, Denmark
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
NovoEight Turoctocog alfa 2000IU Powder for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Gentofte, Denmark
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
NovoEight Turoctocog alfa 3000IU Powder for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Gentofte, Denmark
|
Dated this 29th day of January 2016.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).